{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-040525","form_type":"8-K","ticker":"JANL","cik":"0001133062","company_name":"JANEL CORP","filed_at":"2026-10-22T21:00:27+00:00","discovered_at":"2026-10-22T21:02:00.278914+00:00","generated_at":"2026-10-22T21:02:08.241650+00:00","sec_items":["1.01","2.01","2.03","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Janel acquires EnCor Biotechnology for $17M; $11.96M cash plus $5.04M subordinated note","bullets":["On Oct. 20, 2026, Janel's Antibodies Incorporated bought 100% of Gainesville, Florida-based EnCor Biotechnology, an antibody/reagent maker for neurological disease research.","Base purchase price $17.0M: $11.96M cash at closing plus $5.04M subordinated promissory note; sellers include Gerry Shaw, University of Florida Research Foundation and employee shareholders.","Deferred payments to Shaw of $1.68M each on the first, second and third anniversaries; first payment subject to working-capital adjustment versus $250,000 target.","On Oct. 16, 2026, lenders increased the acquisition facility by $15M; $11M was funded at closing, and EnCor joined as a borrower.","Janel is seeking SEC relief from Rule 3-05 audited EnCor financials, arguing they are not material; no historical or pro forma statements were filed yet."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-040525","json":"https://secwatch.observer/filing/0001140361-26-040525.json","markdown":"https://secwatch.observer/filing/0001140361-26-040525.md","text":"https://secwatch.observer/filing/0001140361-26-040525.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1133062/000114036126040525/0001140361-26-040525-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1133062/000114036126040525/ef20084224_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-22T21:02:08.241650+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}